Elagolix Treatment in Women With Uterine Fibroids: Secondary, 6-Month, Phase 3 Efficacy Results

被引：1
|
作者：
Bradley, Linda D. [1 ]
Feinberg, Eve C. [1 ]
Liu, Ran [1 ]
Owens, Charlotte D. [1 ]
Rodriguez-Ginorio, Henry [1 ]
Simon, James A. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1097/01.AOG.0000558827.87644.32
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
11J
引用
收藏
页码：109S / 109S
页数：1
相关论文
共 50 条
  • [1] Elagolix Reduced Heavy Menstrual Bleeding With Uterine Fibroids: Primary, 6-Month, Phase 3 Results
    Schlaff, William
    Al-Hendy, Ayman
    Barnhart, Kurt
    Owens, Charlotte D.
    Liu, Ran
    Muneyyirci-Delale, Ozgul
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 9S - 9S
  • [2] PHASE 3 TRIAL RESULTS: EFFICACY AND SAFETY OF ELAGOLIX IN A SUBSET OF WOMEN WITH UTERINE FIBROIDS AND ADENOMYOSIS.
    Muneyyirci-Delale, Ozgul
    Archer, David F.
    Kim, Jin Hee Jeannie
    Liu, Ran
    Owens, Charlotte D.
    Puscheck, Elizabeth E.
    FERTILITY AND STERILITY, 2019, 112 (03) : E4 - E4
  • [3] EFFICACY AND SAFETY OF ELAGOLIX IN A SUBGROUP OF WOMEN WITH UTERINE FIBROIDS AND ADENOMYOSIS: RESULTS FROM A PHASE 2 TRIAL
    Taylor, H. S.
    Bedaiwy, M. A.
    Lukes, A. S.
    Chwalisz, K.
    Owens, C.
    Bradley, L.
    FERTILITY AND STERILITY, 2018, 110 (04) : E61 - E61
  • [4] Clinical Utility Of Elagolix As An Oral Treatment For Women With Uterine Fibroids: A Short Report On The Emerging Efficacy Data
    Neri, Manuela
    Melis, Gian Benedetto
    Giancane, Elena
    Vallerino, Valerio
    Pilloni, Monica
    Piras, Bruno
    Loddo, Alessandro
    Paoletti, Anna Maria
    Mais, Valerio
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2019, 11 : 535 - 546
  • [5] ELAGOLIX TREATMENT IN WOMEN WITH HEAVY MENSTRUAL BLEEDING-ASSOCIATED WITH UTERINE FIBROIDS: EFFICACY AND SAFETY RESULTS FROM A PHASE 2B STUDY.
    Simon, J. A.
    Stewart, E. A.
    Owens, C.
    Duan, W. R.
    Gao, J.
    Chwalisz, K.
    FERTILITY AND STERILITY, 2017, 108 (03) : E26 - E27
  • [6] Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women
    Ali, Mohamed
    Sara, A. R.
    Al Hendy, Ayman
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (04) : 427 - 437
  • [7] Efficacy and Safety of Elagolix 150 mg QD in Women With Uterine Fibroids and Heavy Menstrual Bleeding
    Kroll, Robin
    Poindexter, Alfred
    Ng, Juki
    Li, Hong
    Snabes, Michael
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 26S - 26S
  • [8] Incidence of Alopecia in Treatment of Women With Uterine Fibroids: Results of Two Phase 3 Trials of Linzagolix
    Al-Hendy, Ayman
    Taylor, Hugh S.
    Catherino, William
    Stewart, Elizabeth A.
    Bestel, Elke
    Garner, Elizabeth
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 30S - 30S
  • [9] GISSI-3 - 6-MONTH RESULTS
    ROBERTS, A
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1994, 52 (01): : 51 - 51
  • [10] RESULTS OF A 6-MONTH STUDY COMPARING THE SAFETY AND EFFICACY OF NABUMETONE AND ASPIRIN IN THE TREATMENT OF OSTEOARTHRITIS
    MULLEN, BJ
    AMERICAN JOURNAL OF MEDICINE, 1987, 83 (4B): : 74 - 77
12345